Biomarkers in systemic sclerosis: mechanistic insights into pathogenesis and treatment
JR Arron - Current Opinion in Rheumatology, 2021 - journals.lww.com
JR Arron
Current Opinion in Rheumatology, 2021•journals.lww.comCurrent Opinion in Rheumatology Log in or Register Subscribe to journalSubscribe Get new
issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation
Subscribe Register Login Articles & Issues Videos For Authors Journal Info Advanced Search
November 2021 - Volume 33 - Issue 6 Previous Article Next Article RAYNAUD PHENOMENON,
SCLERODERMA, OVERLAP SYNDROMES AND OTHER FIBROSING SYNDROMES: Edited
by John Varga Biomarkers in systemic sclerosis: mechanistic insights into pathogenesis and …
issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation
Subscribe Register Login Articles & Issues Videos For Authors Journal Info Advanced Search
November 2021 - Volume 33 - Issue 6 Previous Article Next Article RAYNAUD PHENOMENON,
SCLERODERMA, OVERLAP SYNDROMES AND OTHER FIBROSING SYNDROMES: Edited
by John Varga Biomarkers in systemic sclerosis: mechanistic insights into pathogenesis and …
Summary
Blood biomarkers related to specific molecular mediators, cell types, and tissues of origin can help to link therapeutic targets to treatable traits in SSc.
Lippincott Williams & Wilkins